Zhang T - Search Results

1

YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies.

Chen Z, Zeng C, Yang L, Che Y, Chen M, Sau L, Wang B, Zhou K, Chen Y, Qing Y, Shen C, Zhang T, Wunderlich M, Wu D, Li W, Wang K, Leung K, Sun M, Tang T, He X, Zhang L, Swaminathan S, Mulloy JC, Müschen M, Huang H, Weng H, Xiao G, Deng X, Chen J. Chen Z, et al. Among authors: zhang l, zhang t. Cell. 2025 Jan 23;188(2):331-351.e30. doi: 10.1016/j.cell.2024.11.007. Epub 2024 Dec 17. Cell. 2025. PMID: 39694037

2

Design, synthesis and anticancer activities evaluation of novel 5H-dibenzo[b,e]azepine-6,11-dione derivatives containing 1,3,4-oxadiazole units.

He X, Li XY, Liang JW, Cao C, Li S, Zhang TJ, Meng FH. He X, et al. Bioorg Med Chem Lett. 2018 Mar 1;28(5):847-852. doi: 10.1016/j.bmcl.2018.02.008. Epub 2018 Feb 8. Bioorg Med Chem Lett. 2018. PMID: 29456106

3

Discovery of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) phenylurea-based thymidylate synthase (TS) inhibitor as a novel multi-effects antitumor drugs with minimal toxicity.

Li XY, Zhang TJ, Kamara MO, Lu GQ, Xu HL, Wang DP, Meng FH. Li XY, et al. Cell Death Dis. 2019 Jul 11;10(7):532. doi: 10.1038/s41419-019-1773-0. Cell Death Dis. 2019. PMID: 31296849 Free PMC article.

4

Small molecular CD73 inhibitors: Recent progress and future perspectives.

Ge GH, Wang QY, Zhang ZH, Zhang X, Guo S, Zhang TJ, Meng FH. Ge GH, et al. Eur J Med Chem. 2024 Jan 15;264:116028. doi: 10.1016/j.ejmech.2023.116028. Epub 2023 Dec 7. Eur J Med Chem. 2024. PMID: 38086190 Review.

5

Synthesis and Biological Evaluation of 5-benzyl-3-pyridyl-1H-1,2,4-triazole Derivatives as Xanthine Oxidase Inhibitors.

Li SY, Zhang TJ, Wu QX, Olounfeh KM, Zhang Y, Meng FH. Li SY, et al. Med Chem. 2020;16(1):119-127. doi: 10.2174/1573406415666190409112209. Med Chem. 2020. PMID: 30963981

6

Design, synthesis, and molecular docking studies of N-(9,10-anthraquinone-2-carbonyl)amino acid derivatives as xanthine oxidase inhibitors.

Zhang TJ, Li SY, Yuan WY, Zhang Y, Meng FH. Zhang TJ, et al. Chem Biol Drug Des. 2018 Apr;91(4):893-901. doi: 10.1111/cbdd.13156. Epub 2018 Jan 8. Chem Biol Drug Des. 2018. PMID: 29197158

7

Design, synthesis, and biological evaluation of 5-(4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl)benzonitrile derivatives as xanthine oxidase inhibitors.

Zhang TJ, Li SY, Zhang Y, Wu QX, Meng FH. Zhang TJ, et al. Chem Biol Drug Des. 2018 Feb;91(2):526-533. doi: 10.1111/cbdd.13114. Epub 2017 Oct 18. Chem Biol Drug Des. 2018. PMID: 28950055

8

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.

Zhang Y, Zhang TJ, Tu S, Zhang ZH, Meng FH. Zhang Y, et al. Molecules. 2020 Sep 8;25(18):4094. doi: 10.3390/molecules25184094. Molecules. 2020. PMID: 32911607 Free PMC article.

9

Design, synthesis and biological evaluation of N-(4-alkoxy-3-(1H-tetrazol-1-yl)phenyl) heterocyclic aromatic amide derivatives as xanthine oxidase inhibitors.

Zhang TJ, Zhang ZH, Zhang X, Wang ZR, Xu EY, Tu S, Zhang Y, Meng FH. Zhang TJ, et al. Bioorg Chem. 2022 Oct;127:105938. doi: 10.1016/j.bioorg.2022.105938. Epub 2022 Jun 9. Bioorg Chem. 2022. PMID: 35752100

10

Development of a novel thymidylate synthase (TS) inhibitor capable of up-regulating P53 expression and inhibiting angiogenesis in NSCLC.

Li XY, Wang DP, Lu GQ, Liu KL, Zhang TJ, Li S, Mohamed O K, Xue WH, Qian XH, Meng FH. Li XY, et al. J Adv Res. 2020 Jul 25;26:95-110. doi: 10.1016/j.jare.2020.07.008. eCollection 2020 Nov. J Adv Res. 2020. PMID: 33133686 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,164 results

Search Page

Filters